Akane Nagasako

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Melanoma has an extremely poor prognosis due to its rapidly progressive and highly metastatic nature. Several therapeutic drugs have recently become available, but are effective only against melanoma with specific BRAF gene mutation. Thus, there is a need to identify other target molecules. We show here that Transient receptor potential, canonical 3 (TRPC3)(More)
  • 1